Physician profile
Antonio Turner
NPI 1649424037
$2,988.59
in general payments reported to CMS, 2019-2025
12 companies · $461 in 2025
The $461 reported for 2025 was more than what 75% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $374 · 2020: $77.90 · 2021: $407 · 2022: $567 · 2023: $392 · 2024: $711 · 2025: $461.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,564.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,563.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $804.53 | 2020-2023 | Acuvue |
| Alcon Vision LLC | $784.33 | 2019-2025 | Hydrus Microstent, Precision 1, Dailies Total1 |
| Bausch & Lomb Americas INC. | $369.20 | 2023-2025 | Miebo, Xiidra, Infuse |
| Tarsus Pharmaceuticals, INC. | $334.09 | 2024-2025 | Xdemvy |
| Oyster Point Pharma, INC. | $224.98 | 2022-2024 | Tyrvaya |
| Glaukos Corporation | $142.56 | 2019-2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $111.88 | 2021 | |
| Dompe US, INC. | $97.46 | 2024 | Oxervate |
| Allergan, INC. | $74.82 | 2021 | |
| Abb Con-Cise Optical Group LLC | $16.62 | 2019 | |
| Lombart Brothers, INC. | $14.70 | 2019 | |
| Kala Pharmaceuticals, INC. | $13.42 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Antonio Turner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.